Shares of Goldman Sachs Group Inc. GS inched 0.15% higher to $586.33 Monday, on what proved to be an all-around mixed trading ...

Goldman Sachs downgraded hospital stocks Universal Health Services (NYSE:UHS) and Tenet Healthcare (NYSE:THC) from buy to ...

The Federal Reserve is likely to signal a slower future pace of easing when it meets later this week and then skip cutting ...

After topping $1 trillion in market cap last week, Broadcom rallied further on Monday, driven by increased price targets from ...

Artificial adoption by companies remains modest, with only 6.1% of U.S. firms currently utilizing AI to produce goods or ...

Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to people familiar with the matter, as it hopes to capitalise on demand for off ...

Goldman Sachs analyst Eric Sheridan initiated coverage on Grindr Inc (NYSE:GRND) with a Buy rating and a price target of $20.

Consumer sentiment and spending will remain strong in 2025, with outsize gains for discretionary stocks, with some ...

BC Partners has agreed to sell its majority stake in Synthon to Goldman Sachs Alternatives. Synthon is an international pharmaceutical company, with a platform specialized in developing, manufacturing ...

Goldman Sachs expects "strategic" deals by companies to accelerate in 2025 including large-scale mergers and acquisitions, ...

Goldman Sachs received regulatory approval to sell funds in China, the latest U.S. investment bank to get a financial licence ...

Goldman Sachs Group Inc. has appointed Omar Alzaim as chief executive officer of its Saudi Arabia operations as it looks to ...